These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3036457)

  • 21. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E; Minetti EE; Cozzi MG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal protective effect of strict blood pressure control with enalapril therapy.
    Bauer JH; Reams GP; Lal SM
    Arch Intern Med; 1987 Aug; 147(8):1397-400. PubMed ID: 2820330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute renal insufficiency caused by observed a combination of enalapril, furosemide and flurbiprofen in a patient with retroperitoneal fibrosis].
    Demontis R; Coevoet B; Guellal A; Fournier A
    Ann Urol (Paris); 1987; 21(5):346-9. PubMed ID: 2827563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.
    Packer M; Kessler PD; Gottlieb SS
    Postgrad Med J; 1986; 62 Suppl 1():179-82. PubMed ID: 3022272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors.
    Oster JR; Materson BJ
    Arch Intern Med; 1992 Apr; 152(4):704-10. PubMed ID: 1558426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypertension and stenosis of the graft artery: effects of conversion enzyme inhibition].
    Mourad G; Ribstein J; Argiles A; Mion C; Mimran A
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):892-5. PubMed ID: 3099707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J; Fraccarollo D
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [24-hour blood pressure and renal function in cardiac failure during the titration phase of captopril and enalapril].
    Osterziel KJ; Dietz R; Abushi A; Kübler W
    Z Kardiol; 1990 Nov; 79(11):742-7. PubMed ID: 2278166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute renal insufficiency due to vomiting or diarrhea: the Achilles heel of medical support for heart failure].
    Jacobs EM; van Leusen R; Bosch FH
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1817-20. PubMed ID: 11020833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory].
    Durand D; Tran Van T; Ader JL; Suc JM
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1272-7. PubMed ID: 6441547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive renal insufficiency induces increasing protection against ischemic acute renal failure.
    Zager RA; Baltes LA
    J Lab Clin Med; 1984 Apr; 103(4):511-23. PubMed ID: 6699471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure.
    Mandal AK; Markert RJ; Saklayen MG; Mankus RA; Yokokawa K
    Clin Nephrol; 1994 Sep; 42(3):170-4. PubMed ID: 7994935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of heart failure with spironolactone--trial and tribulations.
    McMurray JJ; O'Meara E
    N Engl J Med; 2004 Aug; 351(6):526-8. PubMed ID: 15295043
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.
    Funck-Brentano C; Chatellier G; Alexandre JM
    Br Heart J; 1986 Jun; 55(6):596-8. PubMed ID: 3013264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications during enalapril and diuretic therapy for congestive cardiac failure.
    Mehta S; Vijayakumar M
    Indian J Pediatr; 2009 Sep; 76(9):963-4. PubMed ID: 19904515
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure.
    Ikram H; Webster MW; Nicholls MG; Lewis GR; Richards AM; Crozier IG
    Aust N Z J Med; 1986 Feb; 16(1):61-3. PubMed ID: 3010929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal toxicity of enalapril in very elderly patients with progressive, severe congestive heart failure.
    Schwartz D; Averbuch M; Pines A; Kornowski R; Levo Y
    Chest; 1991 Dec; 100(6):1558-61. PubMed ID: 1959395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversible hyperkalemia during antihypertensive therapy in a hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure.
    Uchida K; Azukizawa S; Nakano S; Kaneko M; Kigoshi T; Morimoto S; Matsui A
    South Med J; 1994 Nov; 87(11):1153-5. PubMed ID: 7973905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.